Israel’s Moebius Medical is developing MM-II, a novel treatment for osteoarthritis pain. MM-II’s proprietary liposomes lubricate arthritic knee joints, to reduce friction and wear, and pain in the joints. Moebius has contracted with India’s Sun Pharmaceutical to further develop MM-II.

http://www.globes.co.il/en/article-moebius-and-sun-sign-osteoarthritis-drug-licensing-deal-1001166429